Khadija Saeed, Author at TechStock²

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares

Boston Scientific shares rose about 3.1% to $90.77 Tuesday after the company announced new long-term neuromodulation data for presentation at the NANS meeting in Las Vegas. Investors weighed the news alongside concerns over an FDA alert on AXIOS stents and the $14.5 billion Penumbra acquisition.

20 January 2026

Health News·NYSE:BSX·Stock Market

Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

Capital One shares fell 3.7% to $230.18 Tuesday, trailing the S&P 500 banks index, as investors weighed a possible 10% cap on credit-card interest rates. The company is set to report fourth-quarter results Jan. 22. A federal judge gave preliminary approval to a $425 million class action settlement over its deposit business. Morgan Stanley raised its price target on Capital One to $300.

20 January 2026

NYSE:COF·NYSE:DFS·Stock Market

T-Mobile stock price slides to a fresh 52-week low as tariff jitters hit Wall Street

T-Mobile US shares fell 0.7% to $184.97 by mid-afternoon Tuesday, hitting a new 52-week low of $184.04. The drop followed broad U.S. market declines after renewed tariff threats involving Europe and Greenland. A T-Mobile fee hike takes effect Jan. 21, ahead of its earnings update on Feb. 11. Trading volume reached about 3.7 million shares.

20 January 2026

NASDAQ:TMUS·Stock Market

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck shares traded near $108.82 Tuesday after Merck and Moderna reported their personalized melanoma vaccine with Keytruda cut recurrence or death risk by 49% over five years in a phase 2b trial. The stock showed little change following the update. More data will be presented at a future medical meeting. Investors await Merck’s Feb. 3 earnings call for further details on its oncology portfolio.

20 January 2026

Biotechnology·NASDAQ:MRNA·NYSE:MRK·Pharmaceuticals·Stock Market

Why CrowdStrike stock is sliding today: CRWD hit by tariff jitters despite new cloud plan

CrowdStrike shares fell 2.8% to $441.18 Tuesday as tech stocks slid following President Trump’s tariff threats against Europe. The company announced plans for new in-country clouds in Saudi Arabia, India, and the UAE. Investors shifted focus to upcoming U.S. inflation data and next week’s Federal Reserve meeting. Other cybersecurity stocks, including Zscaler and Palo Alto Networks, also declined.

20 January 2026

Cloud Computing·NASDAQ:CRWD·Stock Market·Technology

Morgan Stanley stock price slides as credit-card rate cap deadline weighs on banks

Morgan Stanley shares fell 3.5% to $182.53 Tuesday afternoon as U.S. bank stocks slid on concerns over a proposed 10% cap on credit-card interest rates. The S&P 500 Banks index dropped 1.2%. The White House has not detailed how the cap would be enforced. Broader markets also declined after President Trump threatened new trade action against Europe.

20 January 2026

NYSE:MS·Stock Market

Chevron stock steadies near $166 as Turkey exploration talks surface and Tengiz outage drags on

Chevron shares were little changed Tuesday after reports of talks with Turkey’s state oil firm on joint exploration. Production at Kazakhstan’s Tengiz oilfield, where Chevron is the largest shareholder, could remain offline for up to 10 days after a shutdown Sunday. Brent crude rose 1.5% on supply concerns. Chevron will report quarterly earnings January 30.

20 January 2026

Energy·NYSE:CVX

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.

20 January 2026

Earnings Reports·NASDAQ:ISRG·Stock Market

Accenture stock (ACN) slides in tariff-hit selloff — what investors watch next

Accenture shares fell 2.8% to $278.07 by early afternoon Tuesday, underperforming the broader U.S. market amid tariff threats tied to Greenland tensions and cautious tech spending outlooks. Morgan Stanley downgraded its view on North American IT hardware, citing weak budget growth. Accenture’s BOSLAN unit secured a role in the East Anglia TWO offshore wind project. Volatility rose across markets as investors reacted to geopolitical risks.

20 January 2026

NYSE:ACN·Stock Market

P&G stock rises as Wall Street slides on tariff fears; earnings next on deck

Procter & Gamble shares rose 1.4% to $146.49 despite a broad market selloff triggered by new U.S. tariff threats on European imports. Barclays raised its price target to $155 but warned recent gains reflect defensive buying, not stronger fundamentals. Investors await P&G’s Jan. 22 earnings call for updates on pricing, costs, and demand. The Cboe Volatility Index hit an eight-week high as traders shifted to consumer staples.

20 January 2026

Earnings Reports·NYSE:PG·Stock Market

Dow Jones sinks 500 points as Trump’s Greenland tariff threat rattles Wall Street

The Dow Jones Industrial Average plunged 582.97 points by midday Tuesday after President Trump announced new tariffs on imports from eight NATO allies, triggering a broad selloff. The S&P 500 and Nasdaq also fell, with declines in tech, banking, and industrial stocks. European leaders plan an emergency summit Thursday in response. The Cboe Volatility Index spiked to its highest level in eight weeks.

20 January 2026

Stock Market

Gold price breaks $4,700 record on tariff fears, lifting GLD and gold miners

Gold surged above $4,700 an ounce Tuesday, hitting a record $4,763.07 as investors reacted to new U.S. tariff threats against Europe. The S&P 500 fell 1.1% and the dollar dropped 0.6%. The Cboe Volatility Index reached its highest level in eight weeks. Traders are watching for President Trump’s pick for the next Fed chair, with an announcement possible next week.

20 January 2026

NYSE:AEM·NYSE:NEM·Precious Metals

Previous 1 … 265 266 267 268 269 … 1,008 Next

Navitas Semiconductor stock jumps 19% into weekend — here’s what could move NVTS next week

7 February 2026

Navitas Semiconductor shares surged 19.3% to $8.86 Friday, with 27.4 million shares traded, as chip stocks rebounded and the Dow closed above 50,000 for the first time. The company’s next earnings report is scheduled for February 24 after market close.

Lumentum stock hits a record close — Citi raises target, insider filing lands ahead of Monday

7 February 2026

Lumentum shares jumped 9.3% to a record $551.99 Friday after Citigroup and JPMorgan raised price targets to $560 and $565. The surge followed strong quarterly results and guidance, plus a director’s filing to sell up to 4,849 shares. Markets reopen Monday ahead of the company’s March 17 investor briefing at OFC.

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

7 February 2026

Nvidia shares jumped 7.9% to $185.41 Friday, their strongest gain in weeks, as chip stocks rallied on news of major AI infrastructure spending by Amazon and Alphabet. The PHLX semiconductor index rose 5.7%. Investors now await U.S. inflation data on Feb. 13 and Nvidia’s earnings report on Feb. 25.

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026

Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.

Khadija Saeed

Stock Market Today